-
E-mail
longlong.liu@dilunbio.com
-
Phone
13240115319
-
Address
802, 8th Floor, Building 21, Tiantong Science and Technology Park, Changping District, Beijing
Beijing Dilun Biotechnology Co., Ltd
Pilot dual channel peptide synthesizer: an efficient tool for peptide research and production
Date: 2025-10-25Read: 3
In the fields of biopharmaceuticals, chemical research, and pharmaceutical development, peptide synthesis is a key technical link that directly affects drug activity, functional research, and industrialization processes. In recent years, with the breakthrough of solid-phase peptide synthesis technology (SPPS), automated peptide synthesizers have become the core equipment in laboratories and production lines. Among them, the 286 MAX pilot dual channel peptide synthesizer has become an ideal choice for peptide research and development in the pilot stage and large-scale production due to its high efficiency, precision, and flexibility.
1、 Technical background: Revolutionary breakthrough in solid-phase synthesis
The core technology of the peptide synthesizer originated from the solid-phase peptide synthesis method (SPPS) invented by Professor Bruce Merrifield in 1963. This method achieves continuous synthesis without purifying intermediate products by connecting amino acids one by one to a solid-phase resin carrier, greatly improving synthesis efficiency and product purity. Professor Merrifield was awarded the Nobel Prize in Chemistry in 1984 for this, and solid-phase synthesis technology has become the cornerstone of modern peptide chemistry.
With technological iteration, peptide synthesizers have undergone three generations of development:
1. The first generation (1960s-1970s) mainly used nitrogen bubbling and stirring to achieve basic automation, but there were problems such as dead corners in the reaction and high solvent consumption.
2. The second generation (1980s) introduced a shaking reactor to optimize mixing efficiency, but the stirring temperature was still limited.
3. The third generation (1990s present): using 360 degree rotating stirring or circular electromagnetic field technology to achieve mixing, such as the ABI 433 synthesizer, which increases the coupling rate to over 99% through high-speed spiral stirring.
The 286 MAX pilot dual channel peptide synthesizer is an optimized upgrade of third-generation technology, designed specifically for pilot scale testing, balancing efficiency and cost.
2、 Product core: Dual channel design, efficient and flexible
1. Dual channel parallel synthesis enhances production capacity
-Simultaneously synthesizing two peptides: each channel is independently controlled, allowing for batch production of different or identical sequences, shortening the research and development cycle.
-Synthesis scale of 2-25 mmol: covering the needs from laboratory research to pilot scale, the single synthesis amount can reach the Dak level, meeting the requirements for peptide quantity in the early stage of drug development.
-Reactor options include 0.5/1/2 L: flexible adjustment based on peptide chain length and synthesis difficulty to avoid resource waste.
2. Precise control to ensure quality
-Synchronous activation and pre activation: supports in situ activation of amino acids, reduces manual operation errors, and ensures sufficient coupling reactions at each step.
-Quantitative accuracy of 1 mL: The extraction error of amino acids and activation reagents is controlled within a very small range to improve repeatability.
-180 ° up and down flipping mechanical stirring: By dynamically mixing, the phenomenon of solid carrier "clumping" is eliminated, avoiding dead corners in the reaction, and the coupling rate is stable at over 98%.
3. Modular design, adaptable to diverse needs
-10 amino acid sites+5 solvent sites: can store multiple amino acids and solvents, supporting complex sequence synthesis.
-20L/50L solvent storage tank: reduces frequent refilling operations and is suitable for long-term continuous synthesis.
-In situ fiber optic temperature control: Accurately monitor the reaction temperature to avoid side reactions caused by temperature fluctuations.
3、 Application scenario: Full chain coverage from research and development to production
1. Drug development
-Active peptide screening: Quickly synthesizing peptide libraries of different sequences for high-throughput drug screening.
-Long peptide chain synthesis: supports the synthesis of peptides with more than 50 amino acids, meeting the needs of complex peptides such as vaccine antigens and hormone analogues.
-GMP production compatibility: The equipment design complies with Good Manufacturing Practice (GMP) and can directly transition to industrial production.
2. Biological research
-Protein structure and function research: synthesis of specific sequence peptides for enzyme activity analysis, receptor binding experiments, etc.
-Immunological research: Preparation of antigen peptides, development of enzyme-linked immunosorbent assay (ELISA) kits, such as the synthesis of Hantavirus nucleocapsid protein antigen peptides.
3. Combinatorial chemistry
-Peptide library construction: Through multi-channel parallel synthesis, rapidly construct diverse peptide libraries for new drug discovery and materials science.
4、 Advantage Comparison: Why Choose 286 MAX?
The 286 MAX pilot dual channel peptide synthesizer has become a key equipment for peptide research and production due to its high efficiency, precision, and flexibility. Whether it is the discovery of breakthrough drugs or the implementation of industrial production, it provides strong support for researchers and engineers.